Publications

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A Consensus Paper by the European Myeloma Network and the Italian Society of Arterial Hypertension.

Main author: Bringhen

DOI: 10.1111/joim.12882

Publication date: February 2019

Read More

Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)

Main author: Dimopoulos

DOI: 10.1182/blood-2013-05-503862

Publication date: January 2013

Read More

Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN).

Main author: Dimopoulos

DOI: 10.1182/blood-2013-05-503862.

Publication date: January 2013

Read More

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

Main author: Ludwig

DOI: 10.1038/s41375-020-01016-0

Publication date: August 2020

Read More

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders

Main author: Ross

DOI: 10.3324/haematol.2011.056176

Publication date: February 2012

Read More

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

Main author: Rawstron

DOI: 10.3324/haematol.11080

Publication date: January 2008

Read More

Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network

Main author: Ozaki

DOI: 10.1159/000357394

Publication date: January 2014

Read More

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.

Main author: Fayers

DOI: 10.1182/blood-2011-03-341669.

Publication date: January 2011

Read More

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

Main author: van de Donk

DOI: 10.3324/haematol.2013.100552

Publication date: July 2014

Read More

The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network

Main author: Terpos

DOI: 10.1093/annonc/mdn796

Publication date: January 2009

Read More

Time From First Symptom Onset to the Final Diagnosis of Multiple Myeloma (MM) – Possible Risks and Future Solutions: Retrospective and Prospective ‘Deutsche Studiengruppe MM’ (DSMM) and ‘European Myeloma Network’ (EMN) Analysis

Main author: Graziani

DOI: 10.1080/10428194.2019.1695051

Publication date: April 2020

Read More

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma.

Main author: Magarotto

DOI: 10.1182/blood-2015-08-662627

Publication date: January 2016

Connected Trials: EMN01

Read More